NuCana BioMed

NuCana BioMed

NuCana BioMed

A clinical stage biopharmaceutical company transforming anti-cancer agents into better and safer medicines that overcome key resistance mechanisms
Type
B2c
Founded
2008
Raised
$167.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$100,000,000
Post-IPO equity - 2017
$57,000,000
Venture capital (Series B) - 2014
Team Size
2
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when NuCana BioMed makes some noise.